Abstract
Non-invasive prenatal testing (NIPT) can not only accurately detect early in pregnancy the presence of chromosomal abnormalities but also fetal sex. However, whether fetal sex should be reported after performing NIPT is ethically contentious. In Belgium, NIPT is practically fully reimbursed and offered to all pregnant women as a first-tier screening. In practice, fetal sex is reported upon request of the expectant parents; however, this is not stipulated in guidelines. As more countries are offering NIPT and looking to implement it in public healthcare, challenges and insights of healthcare professionals working in Belgium can be of value for others. We assessed healthcare professionals’ experiences with and perspectives on sex determination and reporting following NIPT in Belgium by conducting a semi-structured interview study. We interviewed 30 professionals involved in prenatal screening. While overall healthcare professionals did not consider reporting fetal sex to be an issue if the expectant parents want to know, some consider the reporting of a non-medical trait like fetal sex problematic when it is reimbursed or if it could lead to sex-selective termination of pregnancy. Moreover, the strong desire of expectant parents to know fetal sex risks compromising informed decision-making about NIPT. In this way, fetal sex may distract from the primary aim of NIPT as a test for medical conditions. Improving pre-test counseling both in terms of quality and availability may help overcome some of these issues.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
To protect the privacy of the participants, the data on which this paper was built can not be shared publicly. The data can be shared on reasonable request to the corresponding author.
Notes
Sex refers to the biological and genetic make-up of the sex chromosomes, gender refers to socio-cultural and psychological identity. Not everyone has the same gender identity as their chromosomal sex. NIPT is regularly wrongly dubbed as the ‘gender test’ in common discourse. This is inaccurate because it detects chromosomal sex, it does not determine gender.
References
Pasche Guignard F. A gendered bun in the oven: the gender reveal party as a new ritualization during pregnancy. Stud Relig. 2015;44:479–500.
Barnes MW. Anticipatory socialization of pregnant women: learning fetal sex and gendered interactions. Sociol Perspect. 2015;58:187–203.
Barnes MW. Fetal sex determination and gendered prenatal consumption. J Consum Cult. 2015;15:371–90.
Devaney SA, Palomaki GE, Scott JA, Bianchi DW. Noninvasive fetal sex determination using cell-free fetal DNA. JAMA. 2011;306:627–36.
Kearin M, Pollard K, Garbett I. Accuracy of sonographic fetal gender determination: predictions made by sonographers during routine obstetric ultrasound scans. Australas J Ultrasound Med. 2014;17:125–30.
De Jong A, Maya I, van Lith JMM. Prenatal screening: current practice, new developments, ethical challenges. Bioethics. 2015;29:1–8.
De Jong A, de Wert GMWR. Prenatal Screening: An Ethical Agenda for the Near Future. Bioethics. 2015;29:46–55.
Ravitsky V, Roy MC, Haidar H, Henneman L, Marshall J, Newson AJ, et al. The emergence and global spread of noninvasive prenatal testing. Annu Rev Genom Hum Genet. 2021;22:309–38.
Dondorp W, de Wert G, Bombard Y, Bianchi DW, Bergmann C, Borry P, et al. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet. 2015;23:1438–50.
Johnston J, Zacharias RL. The future of reproductive autonomy. Hastings Cent Rep. 2017;47:S6–11.
Newson AJ. Ethical aspects arising from non-invasive fetal diagnosis. Semin Fetal Neonatal Med. 2008;13:103–8.
Browne TK. Why parents should not be told the sex of their fetus. J Med Eth. 2017;43:5–10.
Savulescu J. In defense of selection for nondisease genes. Am J Bioeth. 2001;1:16–9.
Van Den Bogaert K, Lannoo L, Brison N, Gatinois V, Baetens M, Blaumeiser B, et al. Outcome of publicly funded nationwide first-tier noninvasive prenatal screening. Genet Med. 2021;23:1137–42.
Duquenne A, Marichal A, Baetens M, Blaumeiser B, Brison N, Bruneau M, et al. Multicentric longitudinal performance monitoring of different non-invasive prenatal screening technologies used in Belgium. In: Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Oral Presentations. In: Eur J Hum Genet. 2023;31:46–7.
Directoraat-generaal gezondheidszorg. FRPB/2016/ADVIES-4. p. 1–5 Advies van de Federale Raad voor de paramedische beroepen betreffende de “genetic counselor” 2016. Available from: https://overlegorganen.gezondheid.belgie.be/nl/documenten/advies-frpb-201604-betreffende-de-genetic-counselor.
BeSHG. Belgian guidelines for managing incidental findings detected by NIPT [Internet]. 2021. Available from: https://www.college-genetics.be/assets/recommendations/fr/guidelines/BeSHG%20prenatal%20consortium_guidelines%20managing%20incidental%20findings%20detected%20by%20NIPT.pdf.
Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual Res Sport Exerc Health. 2019;11:589–97.
Horn R. NIPT and the concerns regarding ‘routinisation.’ Eur J Hum Genet. 2022;30:637–8.
Kater-Kuipers A, De Beaufort ID, Galjaard RJH, Bunnik EM. Ethics of routine: a critical analysis of the concept of routinisation in prenatal screening. J Med Eth. 2018;44:626–31.
Schöne-Seifert B, Junker C. Making use of non-invasive prenatal testing (NIPT): rethinking issues of routinization and pressure. J Perinat Med. 2021;49:959–64.
Lannoo L, van der Meij KRM, Bekker MN, De Catte L, Deckers S, Devriendt K, et al. A cross‐country comparison of pregnant women’s decision‐making and perspectives when opting for non‐invasive prenatal testing in the Netherlands and Belgium. Prenat Diagn. 2023;43:294–303.
Bunnik EM, Kater-Kuipers A, Galjaard RJH, de Beaufort ID. Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access. J Med Eth. 2020;46:194–8.
Steffensen EH, Skakkebæk A, Gadsbøll K, Petersen OB, Westover T, Strange H, et al. Inclusion of sex chromosomes in noninvasive prenatal testing in Asia, Australia, Europe and the USA: a survey study. Prenat Diagn. 2023;43:144–55.
Stevens C, Llorin H, Gabriel C, Mandigo C, Gochyyev P, Studwell C. Genetic counseling for fetal sex prediction by NIPT: challenges and opportunities. J Genet Coun. 2023:1–12. https://doi.org/10.1002/jgc4.1703.
Bayefsky MJ, Berkman BE. Implementing expanded prenatal genetic testing: should parents have access to any and all fetal genetic information? Am J Bioeth. 2021;22:1–19.
Bowman-Smart H, Savulescu J, Mand C, Gyngell C, Pertile MD, Lewis S, et al. “Is it better not to know certain things?”: views of women who have undergone non-invasive prenatal testing on its possible future applications. J Med Eth. 2019;45:231–8.
Young N, Hallam J, Jackson J, Barnes C, Montague J. Exploring the lived experiences of mothers who identify with ‘gender disappointment.’. J Health Visit. 2021;9:470–6.
Acknowledgements
The authors wish to thank the healthcare professionals who participated in this study for their time and valuable insights. Furthermore, we would like to thank Maria Siermann for helpful feedback, Karuna van der Meij for helpful discussions on the topic, and Lore Lannoo for helpful insights. We would also like to thank the anonymous reviewers for their questions and comments.
Funding
No grants were received for this study.
Author information
Authors and Affiliations
Contributions
Conceptualization: ZC, LH, JRV, PB. Investigation and methodology: ZC, EV. Analysis: ZC, EV, LH. Project administration: ZC. Supervision: LH, JRV, PB. Writing original paper: ZC. Editing and critical revision of paper: ZC, HBS, JRV, LH, PB.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
This study received ethics approval from the Research Ethics Committee UZ Leuven S65668. All participants signed an informed consent form to participate in this study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Claesen-Bengtson, Z., Bowman-Smart, H., Vermeersch, E. et al. Should non-invasive prenatal testing (NIPT) be used for fetal sex determination? Perspectives and experiences of healthcare professionals. Eur J Hum Genet 32, 309–316 (2024). https://doi.org/10.1038/s41431-024-01536-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41431-024-01536-8